These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity. Milano G, Biemmi V, Lazzarini E, Balbi C, Ciullo A, Bolis S, Ameri P, Di Silvestre D, Mauri P, Barile L, Vassalli G. Cardiovasc Res; 2020 Feb 01; 116(2):383-392. PubMed ID: 31098627 [Abstract] [Full Text] [Related]
3. miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b/P53 pathway in doxorubicin-induced cardiotoxicity. Pan JA, Tang Y, Yu JY, Zhang H, Zhang JF, Wang CQ, Gu J. Cell Death Dis; 2019 Sep 11; 10(9):668. PubMed ID: 31511497 [Abstract] [Full Text] [Related]
4. Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway. Du J, Hang P, Pan Y, Feng B, Zheng Y, Chen T, Zhao L, Du Z. Toxicol Appl Pharmacol; 2019 Apr 15; 369():73-81. PubMed ID: 30831132 [Abstract] [Full Text] [Related]
5. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte. Wan GX, Cheng L, Qin HL, Zhang YZ, Wang LY, Zhang YG. Cardiovasc Toxicol; 2019 Jun 15; 19(3):264-275. PubMed ID: 30535663 [Abstract] [Full Text] [Related]
7. MicroRNA-31-5p attenuates doxorubicin-induced cardiotoxicity via quaking and circular RNA Pan3. Ji X, Ding W, Xu T, Zheng X, Zhang J, Liu M, Liu G, Wang J. J Mol Cell Cardiol; 2020 Mar 15; 140():56-67. PubMed ID: 32135167 [Abstract] [Full Text] [Related]
8. Examining the protective role of ErbB2 modulation in human-induced pluripotent stem cell-derived cardiomyocytes. Eldridge S, Guo L, Mussio J, Furniss M, Hamre J, Davis M. Toxicol Sci; 2014 Oct 15; 141(2):547-59. PubMed ID: 25055963 [Abstract] [Full Text] [Related]
10. ERBB4 and Multiple MicroRNAs That Target ERBB4 Participate in Pregnancy-Related Cardiomyopathy. Feyen E, Ricke-Hoch M, Van Fraeyenhove J, Vermeulen Z, Scherr M, Dugaucquier L, Viereck J, Bruyns T, Thum T, Segers VFM, Hilfiker-Kleiner D, De Keulenaer GW. Circ Heart Fail; 2021 Jul 15; 14(7):e006898. PubMed ID: 34247489 [Abstract] [Full Text] [Related]
11. Upregulation of let-7f-2-3p by long noncoding RNA NEAT1 inhibits XPO1-mediated HAX-1 nuclear export in both in vitro and in vivo rodent models of doxorubicin-induced cardiotoxicity. Liu Y, Duan C, Liu W, Chen X, Wang Y, Liu X, Yue J, Yang J, Zhou X. Arch Toxicol; 2019 Nov 15; 93(11):3261-3276. PubMed ID: 31570982 [Abstract] [Full Text] [Related]
12. Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins. Bian Y, Sun M, Silver M, Ho KK, Marchionni MA, Caggiano AO, Stone JR, Amende I, Hampton TG, Morgan JP, Yan X. Am J Physiol Heart Circ Physiol; 2009 Dec 15; 297(6):H1974-83. PubMed ID: 19801490 [Abstract] [Full Text] [Related]
17. Inhibition of cyclin-dependent kinase 7 mitigates doxorubicin cardiotoxicity and enhances anticancer efficacy. Chen J, Wei J, Xia P, Liu Y, Belew MD, Toohill R, Wu BJ, Cheng Z. Cardiovasc Res; 2024 Jul 31; 120(9):1024-1036. PubMed ID: 38646672 [Abstract] [Full Text] [Related]
18. miR-146a Attenuates Sepsis-Induced Myocardial Dysfunction by Suppressing IRAK1 and TRAF6 via Targeting ErbB4 Expression. An R, Feng J, Xi C, Xu J, Sun L. Oxid Med Cell Longev; 2018 Jul 31; 2018():7163057. PubMed ID: 30224945 [Abstract] [Full Text] [Related]